Triple

T13942296
Position Surface form Disambiguated ID Type / Status
Subject Pfizer–BioNTech E335285 entity
Predicate productBrandName P40804 FINISHED
Object Comirnaty
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
E1075482 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Comirnaty | Statement: [Pfizer–BioNTech, productBrandName, Comirnaty]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Comirnaty
Context triple: [Pfizer–BioNTech, productBrandName, Comirnaty]
  • A. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • B. CoronaVac
    CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
  • C. Sputnik V COVID-19 vaccine
    Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
  • D. Janssen COVID-19 Vaccine
    The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
  • E. mRNA-1273
    mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Comirnaty
Triple: [Pfizer–BioNTech, productBrandName, Comirnaty]
Generated description
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Comirnaty
Target entity description: Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
  • A. Vaxzevria COVID-19 vaccine
    Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
  • B. CoronaVac
    CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
  • C. Sputnik V COVID-19 vaccine
    Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
  • D. Janssen COVID-19 Vaccine
    The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
  • E. mRNA-1273
    mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: productBrandName
Context triple: [Pfizer–BioNTech, productBrandName, Comirnaty]
  • A. hasBrandName chosen
    Indicates that an entity is associated with or identified by a specific brand name.
  • B. parentBrand
    Indicates that one brand is the overarching or owning brand from which another brand is derived or subordinated.
  • C. usedBrand
    Indicates that an entity has utilized, applied, or operated a particular brand in some context.
  • D. usedBrandOf
    Indicates that one entity made use of or operated an item, product, or service associated with a particular brand.
  • E. nicknameOfProduct
    Indicates that one term is used as an informal or alternative name (nickname) for a particular product.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c6081b88190b53e317c3370c8fe completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de2e0f6f3c8190a64058b732b0ac52 completed April 14, 2026, 12:07 p.m.
NED1 Entity disambiguation (via context triple) batch_69fbc3201af48190a1746abbf080187d completed May 6, 2026, 10:39 p.m.
NEDg Description generation batch_69fbc62b8b308190bbf13f8536bf4449 completed May 6, 2026, 10:52 p.m.
NED2 Entity disambiguation (via description) batch_69fbc6b13f0481908ba6ff97421c8506 completed May 6, 2026, 10:54 p.m.
PD Predicate disambiguation batch_69de05a3ccf88190b45c742db483fa08 completed April 14, 2026, 9:15 a.m.
Created at: April 9, 2026, 10:17 p.m.